GLP-1 Receptor Agonists are a class of medications used primarily to treat type 2 diabetes. They work by mimicking the action of a natural hormone called glucagon-like peptide-1 (GLP-1), which helps regulate blood sugar levels. These drugs stimulate insulin secretion when blood sugar is high, reduce the amount of glucose produced by the liver, and slow down gastric emptying, leading to improved blood sugar control. In addition to their effects on blood sugar, GLP-1 Receptor Agonists can also promote weight loss by reducing appetite and increasing feelings of fullness. Some common examples of these medications include liraglutide and semaglutide. They are often prescribed alongside lifestyle changes, such as diet and exercise, to enhance overall diabetes management.